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INTRODUCTION
Locally advanced or recurrent colorectal cancer often 
invades into surrounding organs within the narrow pelvic 
space. Such disease is complex to treat, because the patient 
often presents with symptoms of bleeding, obstruction, and 
fistulation [1]. Prognosis for these patients is poor, with a 
median survival less than 1 year. Even patients who receive 
palliative chemotherapy can only extend their lifetime by 10–15 
months [2]. Microscopically complete (R0) resection offers the 
only potential for cure [2,3]. Pelvic exenteration (PE) was first 
described in 1948 and has been indicated for the purpose of R0 
resection of locally invasive pelvic malignancies [4]. However, 
PE is a highly invasive procedure, and extensive resection 
often correlates with higher morbidity and mortality rates [5]. 
A previous systemic review showed overall complication rates 
ranging between 31.6% and 86%, with a high proportion of 
patients requiring surgical intervention for complications (14.6%) 
[5]. Further, the mortality rate ranged between 5% and 23%, 
even with advanced operative techniques and perioperative 
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Purpose: Pelvic exenteration (PE) is a highly invasive procedure with high morbidity and mortality rates. Promising options 
to reduce this invasiveness have included laparoscopic and transperineal approaches. The aim of this study was to identify 
the safety of combined transabdominal and transperineal endoscopic PE for colorectal malignancies.
Methods: Fourteen patients who underwent combined transabdominal and transperineal PE (T group: 2-team approach, 
n = 7; O group: 1-team approach, n = 7) for colorectal malignancies between April 2016 and March 2020 in our institutions 
were included in this study. Clinicopathological features and perioperative outcomes were compared between groups.
Results: All patients successfully underwent R0 resection. Operation time tended to be shorter in the T group (463 
minutes) than in the O group (636 minutes, P = 0.080). Time to specimen removal was significantly shorter (258 minutes vs. 
423 minutes, P = 0.006), blood loss was lower (343 mL vs. 867 mL, P = 0.042), and volume of blood transfusion was less (0 
mL vs. 560 mL, P = 0.063) in the T group, respectively. Postoperative complications were similar between groups.
Conclusion: Combined transabdominal and transperineal PE under a synchronous 2-team approach was feasible and safe, 
with the potential to reduce operation time, blood loss, and surgeon stress.
[Ann Surg Treat Res 2021;101(2):102-110]
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care. Median incomplete resection rate (R1/R2) was relatively 
high, at 18.9%. Microscopic advanced disease and the difficulty 
of handling large tumors in the narrow pelvis could reflect a 
positive circumferential margin. Accomplishing both surgical 
and oncological safety would maximize the benefit from the 
procedure.
Laparoscopic surgery for colorectal cancer has become 
established as an alternative to open surgery [6]. Previous 
randomized controlled studies have demonstrated potential 
advantages of laparoscopic surgery with regard to short-term 
outcomes, including lower blood loss, faster recovery, and 
lower rates of postoperative complications [6,7]. In the past, PE 
was usually performed under an open approach [8]. However, 
several recent reports have suggested laparoscopic PE as a 
feasible and oncologically safe alternative to the open approach 
[9-11].
Transperineal surgery is another promising approach for 
rectal cancer [12]. The approach can be performed from the 
lower edge of the tumor for direct visualization, which could 
facilitate safe distal margins [13]. A multidirectional approach 
may keep dissection within an appropriate layer, which could 
improve the rate of R0 resection. Furthermore, when the surgery 
was performed under a 2-team approach, with transabdominal 
and transperineal teams operating simultaneously, better 
perioperative outcomes including shorter operation time and 
lower blood loss appeared achievable [14]. 
PE using a transperineal approach is reported to have 
potential for reducing operation time, blood loss, and surgical 
stress, though few case reports have examined these potential 
benefits [15,16]. 
The aim of this study was to identify the feasibility and safety 
of combined transabdominal and transperineal endoscopic PE. 
We also examined the effectiveness of the procedure under a 
2-team approach.
METHODS
This multicenter, retrospective study was designed by the 
Nagasaki Colorectal Oncology Group. Between April 2016 
and March 2020, 20 patients who underwent combined 
transabdominal and transperineal endoscopic PE for colorectal 
malignancies in participating hospitals were included in this 
study. Patients with distant metastasis and emergency surgery 
were excluded. A final total of 14 patients were eligible for 
analysis. All patients were diagnosed by physical examination, 
blood tests, computed tomography, magnetic resonance 
imaging, and colonoscopy. Indications for perioperative 
chemotherapy and resectability were discussed at team 
meetings. Total PE was defined as en bloc resection of the 
rectum, bladder, uterus and vagina in females, prostate in 
males, and lateral pelvic lymph nodes. Posterior PE was defined 
as en bloc resection of the rectum, and vagina in females, 
sparing the bladder. The study was reviewed and approved 
by the Clinical Research Review Board of Nagasaki University 
Hospital and Sasebo City General Hospital (No. 16062715-2) 
with the written informed consent. 
Surgery was performed as transabdominal and transperineal 
parts. The patient was placed in a Trendelenburg lithotomy 
position. The transabdominal part was performed using 5 ports; 
12-mm ports at the umbilicus and right lower quadrant, and 
5-mm ports at the upper right and left and lower left quadrants. 
Medial-to-lateral retroperitoneal resection was performed first. 
The inferior mesenteric artery and vein were then resected. 
The descending colon was dissected by taking down Toldt’s 
fusion fascia. After resecting the mesentery of the sigmoid 
colon, the sigmoid colon was transected using a linear stapler. 
Bilateral ureters were mobilized and dissected at the level of 
the ureterovesical junction. After the hypogastric nerve was 
resected at the level of the aortic branch, the surgeon dissected 
the posterior rectal space. Branches of the internal iliac vessels 
were clipped and resected, then lateral pelvic lymph node 
dissection was performed bilaterally. On the anterior side, the 
space of Retzius was dissected and the dorsal vein complex 
(DVC) was exposed.
In the transperineal part, the anus was closed using a double 
purse-string suture. After making the perianal skin incision, 
the GelPOINT Path® (Applied Medical, Rancho Santa Margarita, 
CA, USA) was set. Three ports were installed, then the perianal 
fat tissue was dissected and the levator ani muscle was exposed 
posteriorly. Anteriorly, the transverse perineal muscle and 
branch of the internal pudendal vessels were resected using 
a vessel sealer. The bulbocavernous muscle was divided using 
the vessel-sealing system. The urethra was then clipped and 




Fig. 1. Transperineal view before dissecting the urethra and 
dorsal vein complex (DVC). Written informed consent was 
obtained for this image.
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transected. The DVC was identified and divided using the 
vessel-sealing system (Fig. 1), and rendezvous was achieved. 
Finally, the specimen was extracted through the abdominal 
wound (Fig. 2). An ileal conduit reservoir was constructed 
through the umbilical wound. Schematic diagrams of the PE 
procedure presented in this study are presented in Fig. 3.
Surgery performed by a transabdominal team and a 
transperineal team working simultaneously was defined 
as the 2-team approach (T group), while that performed 
separately was the 1-team approach (O group). We excluded 
patients who required a large skin incision in the perineal 
region from the 2-team approach, as we could not perform 
the laparoscopic approach from the anal side. To compare 
clinical features between groups, the following data were 
collected; sex, age at surgery, body mass index (BMI), American 
Society of Anesthesiologists (ASA) performance status (PS) 
classification, comorbidity, preoperative diagnosis, histological 
type, and preoperative treatment. Surgical and pathological 
data, including the operative procedure, lateral lymph node 
dissection, proportion of conversion to open surgery, operation 
time, time to specimen removal, estimated blood loss, blood 
transfusion, tumor size, lymphovascular invasion, number 
of retrieved lymph nodes, R0 resection rate, postoperative 
complications, pathological stage, postoperative hospital 
stay, and postoperative treatment were also compared 
between groups. Some patients did not receive postoperative 
chemotherapy based on the decision of the attending physician, 
the wishes of the patient, or the poor general condition of the 
patient due to postoperative complications.
Postoperative complications were defined as complications 
that occurred within 30 days of the primary surgery. Patients 
with complications of Clavien-Dindo (CD) grade 2 or higher 
were included in the complication group. Patients with 
recurrence during follow-up were also investigated for primary 
tumor site, surgical approach, postoperative chemotherapy, 
time to adjuvant chemotherapy, recurrence site, treatment after 
recurrence, and prognosis.
Statistical analysis was performed using bell curve for Excel 
version 2.02 software (Social Survey Research Information 
Corp., Tokyo, Japan). Data are presented as median values with 
ranges. Differences in categorical variables were compared 
using Fisher exact test or the chi-square test, as appropriate. 
Differences in continuous variables were analyzed using the 
Mann-Whitney U-test. All P-values of <0.05 were considered 
significant.
RESULTS
Table 1 shows clinical differences between the T group and 
O group. Sex, age, BMI, ASA PS classification, comorbidities, 
preoperative diagnosis, histological type, and preoperative 
treatment were comparable between groups.
Table 2 shows the surgical and pathological differences 
between the T group and O group. Operation time and 
estimated blood loss in all patients were 562 minutes (range, 
307–738 minutes) and 140 mL (range, 130–1,660 mL). All 
patients successfully underwent R0 resection. Operation time 
tended to be shorter in the T group (463 minutes) than in the 
O group (636 minutes, P = 0.080). Time to specimen removal 
was significantly shorter (258 minutes vs. 423 minutes, P = 
0.006), blood loss was lower (343 mL vs. 867 mL, P = 0.042), 
and blood transfusion was less (0 mL vs. 560 mL, P = 0.063) in 
the T group. One patient in the T group required conversion to 
open surgery due to uncontrolled intraoperative bleeding. No 













Fig. 2. Transperineal view after total pelvic exenteration with 
lateral lymph node dissection. Written informed consent was 
obtained for this image. EIA, external iliac artery; EIV, external 




Fig. 3. Schematic diagrams of the pelvic exenteration proce-
dure presented in this study. Arrowheads, transabdominal 
approach; arrows, transperineal approach.
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remaining factors, including operative procedure, lateral lymph 
node dissection, tumor size, lymphovascular invasion, retrieved 
lymph nodes, postoperative complications, pathological 
stage, postoperative hospital stay, proportion of postoperative 
chemotherapy, and time to adjuvant chemotherapy.
Table 3 shows the patients who experienced recurrence after 
PE. Median follow-up for all patients was 21 months (range, 
2–46 months). Five patients (35.7%) experienced recurrence 
during follow-up. The primary tumor site was the sigmoid 
colon in 3 patients and the rectum in 2 patients. Four cases 
were treated using a 1-team approach. Four patients received 
postoperative chemotherapy (fluorouracil [FU] in 1 patient; 
FU + oxaliplatin in 3 patients). Duration from surgery to 
adjuvant chemotherapy was 68 days (range, 52–76 days). Sites 
of recurrence were the paraaortic lymph nodes, lungs, and liver 
in 1 patient each. Two patients experienced local recurrence. 
Time from surgery to recurrence was 10 months (range, 5–26 
months). With regard to treatment after recurrence, 4 patients 
received systemic chemotherapy and 1 patient underwent 
surgery.
DISCUSSION
Our results showed that combined transabdominal and 
transperineal endoscopic PE offered good perioperative 
outcomes, including low blood loss and a low complication 
rate. All patients achieved complete R0 resection. Furthermore, 
the procedure performed using a 2-team approach (abdominal 
and perineal teams simultaneously) shortened operation time 
and decreased blood loss and blood transfusion compared to 
the 1-team approach. To the best of our knowledge, this is the 
first study to investigate the safety, feasibility, and oncological 
outcomes of combined transabdominal and transperineal 
endoscopic PE.
PE includes en bloc removal of the rectum with bladder and 
reproductive organs for the purpose of complete R0 resection 
[17]. However, patients who underwent the procedure often 
experienced excessive stress, long operation time, high blood 
loss, delayed postoperative recovery, and high morbidity rates 
[18,19]. These days, laparoscopic surgery has become popular 
for colorectal malignancies due to the reduced invasiveness 
Table 1. Comparison of clinical characteristics between patients who underwent combined transabdominal and 
transperineal pelvic exenteration with 1- (O group) and 2-team approaches (T group)
Characteristic Total T group O group P-value
No. of patients 14 7 7
Sex 0.559
   Male 10 (71.4) 4 (57.1) 6 (85.7)
   Female 4 (28.6) 3 (42.9) 1 (14.3)
Age (yr) 68 (41–73) 69 (61–71) 57 (41–73) 0.073
Body mass index (kg/m2) 21 (16–30) 21 (16–24) 23 (18–30) 0.193
ASA PS classification >0.999
   I 5 (35.7) 3 (42.9) 2 (28.6)
   II 9 (64.3) 4 (57.1) 5 (71.4)
Comorbidity >0.999
   No 5 (35.7) 3 (42.9) 2 (28.6)
   Yes 9 (64.3) 4 (57.1) 5 (71.4)
Preoperative diagnosis 0.286
   Primary tumor 12 (85.7) 5 (71.5) 7 (100)
      Sigmoid colon 4 (28.6) 2 (28.6) 2 (28.6)
      Rectal cancer 8 (57.1) 3 (42.9) 5 (71.4)
   Recurrent tumor 2 (14.3) 2 (28.6) 0 (0)
Histological type >0.999
   Well/moderate 13 (92.9) 7 (100) 6 (85.7)
   Mucinous/poor 1 (7.1) 0 (0) 1 (14.3)
Preoperative treatment >0.999
   No 1 (7.1) 0 (0) 1 (14.3)
   Yes 13 (92.9) 7 (100) 6 (85.7)
      Systemic chemotherapy   8 4 4
      CRT   5 3 2
Values are presented as number only, number (%), or median (range).
ASA, American Society of Anesthesiologists; PS, performance status; CRT, chemoradiotherapy.
Differences in categorical variables were compared using Fisher exact test or the chi-square test, as appropriate. Differences in 
continuous variables were analyzed using the Mann-Whitney U-test.
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compared to open surgery [6,7].
Some recent studies have investigated the feasibility of 
laparoscopic PE [9,11]. Ogura et al. [9] examined the safety and 
feasibility of laparoscopic PE in patients with colorectal cancer. 
Estimated blood loss (930 mL vs. 3,003 mL, P = 0.001) and 
volume of blood transfusion (0 mL vs. 1,990 mL, P = 0.002) 
were significantly lower in patients undergoing laparoscopic 
PE than in patients undergoing open PE. Operation time 
(829 minutes vs. 875 minutes, P = 0.660) and proportion of 
postoperative complications (61.5% vs. 83.3%, P = 0.171) were 
similar between groups. They concluded that laparoscopic PE 
could represent a safe and preferred option with significant 
Table 2. Comparison of perioperative outcomes between patients who underwent combined transabdominal and 
transperineal PE with 1- (O group) and 2-team approaches (T group)
Variable Total  (n = 14) T group  (n = 7) O group  (n = 7) P-value
Operative procedure 0.559
   Total PE 10 (71.4) 4 (57.1) 6 (85.7)
   Posterior PE 4 (28.6) 3 (42.9) 1 (14.3)
Lateral lymph node dissection >0.999
   No 5 (35.7) 3 (42.9) 2 (28.6)
   Yes 9 (64.3) 4 (57.1) 5 (71.4)
   Conversion to open surgery, yes 1 (7.1) 1 (14.3) 0 >0.999
Operation time (min) 562 (307–738) 463 (307–649) 636 (318–738) 0.080
   Abdominal approach 560 (250–680)
   Perineal approach 76 (58–132)
Time to specimen removal (min) 326 (196–548) 258 (196–420) 423 (271–548) 0.006
Estimated blood loss (mL) 618 (130–1,660) 343 (252–1,410) 867 (130–1,660) 0.042
Blood transfusion (mL) 140 (0–1,120) 0 (0–1,120) 560 (0–1,120) 0.063
Blood transfusion 0.102
   No 3 (21.4) 2 (28.6) 1 (14.3)
   Yes 11 (78.6) 5 (71.4) 6 (85.7)
Tumor size (mm) 90 (30–160) 60 (30–140) 90 (90–160) 0.142
Lymphovascular invasion 0.559
   No 10 (71.4) 6 (85.7) 4 (57.1)
   Yes 4 (28.6) 1 (14.3) 3 (42.9)
Retrieved lymph node 23 (2–45) 17 (2–45) 25 (12–40) 0.385
Retrieved lateral lymph node 6 (1–23) 7 (1–23) 6 (4–14) 0.517
R0 resection, yes 14 (100) 7 (100) 7 (100) >0.999
Postoperative complication 10 (71.4) 5 (71.4) 5 (71.4)
   CD ≥ 2 8 (64.3) 3 (57.1) 5 (71.4) >0.999
      Paralytic ileus 5 1 4
      Urinary tract infection 2 1 1
      Surgical site infection 1 1 0
   CD ≥ 3 1 (7.1) 1 (14.3) 0 >0.999
      Abdominal abscess 1 1 0
Mortality 0 0 0 >0.999
pStage of primary colorectal cancer >0.999
   II 3 (21.4) 1 (14.3) 2 (28.6)
   III 11 (78.6) 6 (85.7) 5 (71.4)
Postoperative hospital stay (day) 23 (10–48) 22 (18–38) 30 (10–48) 0.865
Postoperative chemotherapy >0.999
   No 5 (35.7) 3 (42.9) 2 (28.6)
   Yes 9 (64.3) 4 (57.1) 5 (71.4)
      FU 2 0 2
      FU + oxaliplatin 7 4 3
Time to adjuvant chemotherapy (day) 65 (45–83) 61 (53–76) 67 (45–83) 0.961
Values are presented as number (%), median (range), or number only.
PE, pelvic exenteration; DVC, dorsal vein complex; CD, Clavien-Dindo; pStage, pathological stage; FU, fluorouracil. 
Differences in categorical variables were compared using Fisher exact test or the chi-square test, as appropriate. Differences in 
continuous variables were analyzed using the Mann-Whitney U-test.
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advantages in terms of reducing blood loss. However, 
laparoscopic approaches are sometimes difficult in cases with 
a narrow pelvis, bulky tumor, male sex, or obesity, due to 
restrictions placed on handling instruments in the deep pelvic 
space [20]. In terms of laparoscopic PE, patients often have large 
tumors with invasion to surrounding organs. In the present 
cases, most patients (10 patients, 71.4%) showed tumors of >90 
mm in maximum diameter.
To overcome these restrictions, we performed the 
transperineal endoscopic approach a long with the 
transabdominal approach. The transperineal approach is an 
extension of the conventional abdominal approach used for 
lower rectal surgery [20]. Surgeons using this approach from a 
“down-to-up” direction could perform deep pelvic dissection 
despite the aforementioned obstacles. As a result, we were 
able to reduce inadequate plane dissection and unnecessary 
blood loss, which could have contributed to the reduced rates 
of postoperative complications. A recent meta-analysis showed 
that the transperineal approach for rectal surgery offers 
advantages in the form of the same circumferential resection 
margins, reduced blood loss, shorter hospital stay, and lower 
postoperative complication rates [20].
Transperineal endoscopic PE has potential with regard to 
safe R0 resection. Despite recent advances in neoadjuvant 
chemotherapy and careful preoperative patient selection, the 
R0 resection rate of PE remains unsatisfactory, in the range of 
41.7%–90.2% [5]. Control of intraoperative bleeding enables the 
surgeon to dissect the appropriate layer, which can facilitate 
completion of R0 resection. In transperineal endoscopic PE, the 
surgeon can detect fine vessels and stop bleeding as soon as 
this occurs under high-definition and magnified visualization, 
especially for angiogenesis around the main tumor. 
Furthermore, high pneumoperitoneal pressure could reduce 
small venous oozing. Management of the DVC is an important 
point for controlling total blood loss in total PE. Dissection of 
the DVC from an abdominal approach is sometimes difficult 
to address due to huge pelvic tumors. With the transperineal 
approach, we could handle the DVC under close visualization 
and an appropriate angle, making the DVC easy to divide using 
only energy devices.
Recurrent rectal cancer is a major indication for PE and 
represents a risk factor for margin-positive resection due 
to severe fibrosis around the tumor [21]. A transperineal 
approach for recurrent cancers could start dissection from an 
untouched area, avoiding effects from the primary surgery. 
A multidirectional approach could help maintain a proper 
dissection layer, resulting in reduced intraoperative bleeding 
and successful R0 resection.
In this study, total blood loss (median, 618 mL; range, 130–
1,660 mL) was broadly similar to that of previous laparoscopic 
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descriptions of open PE (median, 875–2,769 mL) [9,10,22]. In 
addition, all patients (including 2 patients [14.3%] with recurrent 
cancer) achieved R0 resection.
The present study compared laparoscopic PE performed 
by a transabdominal team and a transperineal team working 
simultaneously (2-team approach) with that performed 
separately (1-team approach). The 2-team approach offers 
several benefits not seen with the 1-team approach. First, 
cooperative surgery shortens the dissection time, shortening 
the total operation time compared with the 1-team approach, 
and thus reducing accumulated bleeding. When the abdominal 
and pelvic cavity become one, with the achievement of the so-
called “rendezvous,” the 2 teams can work together to facilitate 
exposure of the appropriate operation field, decreasing surgeon 
fatigue and stress. Unexpected bleeding that is difficult to 
control from one side may prove controllable by the other team. 
Cooperation in tissue exfoliation, development of the operation 
field, and bleeding control could overcome the drawbacks of 
laparoscopic PE. Previous case reports have revealed benefits 
for appropriate dissection and reduced bleeding from 2-team 
procedures for extended pelvic surgery [16,23]. In our study of 
laparoscopic PE, the 2-team approach contributed to shorter 
operation time, lower blood loss, lower blood transfusion, and 
appropriate dissection.
In a previous meta-analysis, intraoperative stress on the 
surgeon was increased with longer operation time, bleeding, 
and less communication [24]. From the results in this study, we 
speculate that a comprehensive 2-team approach would reduce 
stress on the surgeon. Objective data on surgeon stress need 
to be measured to clarify the influences of the approach on 
operator stress [25,26].
On the other hand, a key problem of the cooperative 2-team 
approach is the need for more personnel compared to the 
1-team approach. The procedure is thus more expensive, and 
the operation field often becomes crowded. Recently, a case 
series of robot-assisted anterior PE was reported [27]. They 
observed operation time and length of hospital stay were 
similar to those of conventional laparoscopic surgery. However, 
robotic PE reduced the amount of blood loss, with no patients 
needing blood transfusion. They also showed that robotic PE 
provided good prognosis with no positive margins. Atallah et al. 
[28] reported a new robotic system for dual-field synchronous 
transanal total mesorectal excision (TME) in a preclinical 
model. Because robotic surgery minimizes the need and roles 
for an assistant, the 2-team approach could reduce personnel 
to only the 2 console surgeons along with a surgical assistant 
or expert scrub nurse. These new promising options could 
overcome the drawbacks of synchronous 2-team PE.
The present study had some limitations that merit 
consideration. First, this was a retrospective, nonrandomized 
study with a small number of patients. In this study, although 
operation time was shorter in the 2-team approach, morbidities 
and hospital stay were the same between the 2 approaches. 
One possible explanation is that the number of patients was 
relatively small. Another explanation is that several hospitals 
in areas of different characteristics participated in this study, 
including both high-volume and low-volume centers. The 
duration of hospital stay also varied between hospitals. Second, 
the transperineal approach showed a prolonged learning curve 
because of the differences in anatomical recognition. Recent 
studies of the transanal TME learning curve revealed that 
institutional proficiency was achieved after over 40 cases [29,30]. 
Furthermore, a recent study showed that time to recurrence 
was short, at a median of 11 months after transanal TME. They 
described an increased rate of local recurrence after transanal 
TME due to the learning curve regarding technical problems 
[31]. In the present study of patients at a more advanced stage, 
5 patients (35.7%) experienced recurrence. Among those, 2 
patients (14.3%) showed local recurrence. Training using a 
structured curriculum is crucial for transperineal surgery 
[32]. Third, in this study, performance of the 2-team approach 
was limited to hospitals with experienced surgical teams and 
sufficient staffing. A prospective, randomized study is required 
to overcome these selection biases. To generalize the 2-team 
approach, surgeons must first accumulate experience with 
transperineal surgery. Novel approaches including robotic 
surgery could overcome staffing problems in the future [25].
Despite these limitations, we concluded that combined 
transabdominal and transperineal endoscopic PE using a 
synchronous 2-team approach represents a feasible, safe 
procedure with the potential to reduce operation time, blood 
loss, and stress on the surgeons.
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